So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate
106 This reform aimed to refocus the companys efforts on areas with higher revenue potential, such as respiratory and HIV treatments, as well as oncology and immunology
This process provides energy and keeps blood sugar levels balanced
Back de Leiva, A, Brugus, E, de Leiva-Prez, A (Nov 2011) 'El descubrimiento de la insulina: continan las controversias despus de noventa aos', Endocrinologa, Diabetes y Nutricin , 58, 449-56
Eli Lilly and Company Investor Relations
For context, peptide powders are typically lyophilised (freeze-dried) to improve stability